BIO News and Press, Bio-Rad Laboratories Inc. Class A From 07/10/23

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the second quarter of 2023 on Thursday, August 3, 2023, following the close of the market. Management will discuss these results in a c...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today released its corporate sustainability report for fiscal year ended December 31, 2022. The report has been prepared with reference to the Global Reporting Initiativ...

2023-06-29 05:02:34 ET For further details see: Goldman adds 39 new stocks to its Sharpe Ratio basket with megacaps absent

2023-06-10 18:55:00 ET The Citi quantitative team is still confident about its Oversold Strategy, despite a second stumble in returns this year. "Our systematic Oversold Strategy posted its second loss (-4%) this year in May, as the equity market is following more closely on the credit ...

2023-06-07 07:19:06 ET Summary Coinbase Global faces a lawsuit from the SEC, alleging it operates as an unregistered securities broker, causing its stock to tumble 12% on Tuesday. Apple reportedly acquires augmented-reality start-up Mira, which supplies technology for theme parks ...

2023-06-02 15:00:55 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, will present a company overview at the Jefferies Healthcare Conference on Thursday, June 8, 2023, at 3 PM Eastern Ti...

2023-05-16 06:18:15 ET Summary Bio-Rad previously experienced a significant jump in sales due to Covid-19 testing. However, with Covid-related sales falling off, the overall revenue has also been reduced in 2022. Bio-Rad has experienced wild volatility in recent months, which ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a fireside chat event during the 2023 RBC Capital Markets Global Healthcare Conference on Wednesday,...

2023-05-04 22:48:02 ET Bio-Rad Laboratories, Inc. (BIO) Q1 2023 Results Conference Call May 04, 2023 05:00 PM ET Company Participants Ed Chung - Vice President, Investor Relations Norman Schwartz - Chief Executive Officer Ilan Daskal - Executive Vice President &a...